[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Yang Li\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":76},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,48],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100649350","self-compassion-health-and-empowerment-100649350",false,"NCT07733531","Self-Compassion, Health, and Empowerment","Self-Compassion, Health, and Empowerment: A Randomized Controlled Trial for Chinese Immigrant Women Experiencing Intimate Partner Violence","SHE RCT","Inclusion Criteria:\n\n* Age 18 or older;\n* Self-identify as a woman;\n* Self-identify as Chinese;\n* Reside in the U.S.;\n* Self-report experiences of any physical, emotional, or sexual violence from an intimate partner within the past year;\n* Self-report symptoms of depression, anxiety, or post-traumatic stress disorder (PTSD).\n\nExclusion Criteria:\n\n* Those who cannot speak or understand Mandarin or English;\n* Those with substance use, suicidality, or who have been in mental health care for severe mental illness.","FEMALE","18 Years",{"count":20,"type":21},364,"ESTIMATED","INTERVENTIONAL",[24],"NA","Intimate partner violence (IPV) can have serious and lasting effects on women's mental health and well-being. Chinese immigrant women in the United States often face additional barriers to obtaining IPV and mental health support, including language, cultural, and social challenges. There is a need for culturally appropriate interventions that improve access to care and address the mental health needs of this underserved population.\n\nThe purpose of this study is to evaluate the efficacy of the Self-Compassion, Health, and Empowerment (SHE) intervention, a culturally tailored mobile health (mHealth) program designed for Chinese immigrant women experiencing IPV. Participants will be randomly assigned to either the SHE intervention or an attention control program and will complete study assessments over a 12-month follow-up period.\n\nThe results of this study will help determine whether the SHE intervention improves mental health and well-being among Chinese immigrant women experiencing IPV and may provide evidence for an accessible, culturally appropriate intervention that can be implemented more broadly.",[27,28,29],"Intimate Partner Violence (IPV)","Depression and\u002For Anxiety Symptoms","PTSD - Post Traumatic Stress Disorder",[31,32,33,34],"Empowerment","Self-compassion","mindfulness","safety","NOT_YET_RECRUITING","2026-07-28",{"date":38,"type":39},"2026-07-30","ACTUAL",{"date":41,"type":21},"2026-09-01",{"date":43,"type":21},"2030-08-31",{"name":45,"class":46},"Yang Li","OTHER",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":4,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":55,"minAge":4,"maxAge":18,"enrollmentInfo":56,"targetDuration":4,"studyType":22,"phases":58,"briefSummary":60,"conditions":61,"keywords":65,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":47},"100522854","phase-2-arsenic-trioxide-combined-with-chemotherapy-for-the-treatment-of-p53-mutated-pediatric-cancer-100522854","NCT06088030","Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer","Clinical Research on Efficacy and Safety of Arsenic Trioxide Combined With Chemotherapy in p53-mutated Pediatric Cancer Patients：A Prospective，Single-arm, Multi-center Study","Inclusion Criteria:\n\n1. Pathological diagnosis basis of malignant tumor；\n2. Patients not more than 18 years old;\n3. Patient has either germline or somatic p53 mutations, which was shown to be partially\u002Fcompletely restored to function by ATO in in vitro experiments (http:\u002F\u002Fwww.rescuep53.net);\n4. There are measurable lesions;\n5. Guardians agreed and signed informed consent.\n\nExclusion Criteria:\n\nPatients with one or more critical organs failure such as heart, brain, kidney failure.","ALL",{"count":57,"type":21},50,[59],"PHASE2","This prospective, single-arm, multi-center clinical trial aims to explore and evaluate the efficacy and safety of arsenic trioxide combined with chemotherapy for pediatric cancer with p53 mutation.",[62,63,64],"Pediatric Cancer","Li-Fraumeni Syndrome","p53 Mutations",[66],"Arsenic Trioxide","RECRUITING","2024-01-02",{"date":70,"type":39},"2024-01-03",{"date":72,"type":39},"2023-12-13",{"date":74,"type":21},"2031-12-14",{"name":45,"class":46},""]